☆ 4.5 Letter

Graft Programmed Death Ligand 1 Expression as a Marker for Transplant Rejection Following Anti-Programmed Death 1 Immunotherapy for Recurrent Liver Tumors

LIVER TRANSPLANTATION (2021)

Get Full Text
Add to Collection

Journal

LIVER TRANSPLANTATION
Volume 27, Issue 3, Pages 444-449

Publisher

WILEY
DOI: 10.1002/lt.25887

Keywords

-

Categories

Gastroenterology & Hepatology Surgery Transplantation

Funding

  1. National Key R&D Program of China [2019YFC1315800, 2019YFC1315802]
  2. Shanghai Municipal Key Clinical Specialty
  3. National Natural Science Foundation of China [81972232, 81830102, 81772578]
  4. Shanghai Municipal Natural Science Foundation [18410720700]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.